A Cannabinoid Antagonist for Dying COVID Patients?
Project CBD
JUNE 10, 2020
French scientists promote cannabinoid antagonist as a treatment for COVID -19
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Project CBD
JUNE 10, 2020
French scientists promote cannabinoid antagonist as a treatment for COVID -19
Americans for Safe Access
OCTOBER 28, 2024
This election year, Capitol Hill buzzed with discussions about cannabis scheduling, hemp regulations, and the FDA’s evolving role in regulating cannabinoids. Yet, missing from these debates was one critical topic: the future of medical cannabis and protections for patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MAY 26, 2020
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Project CBD
AUGUST 3, 2020
An oncologist and an osteopath discuss cannabis therapy for cancer patients.
Project CBD
SEPTEMBER 25, 2018
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. New: This report is now available in Spanish and Japanese translations! See bottom of this article for downloads.
NORML
FEBRUARY 19, 2021
“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.".
Americans for Safe Access
MARCH 24, 2020
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
NORML
JULY 28, 2021
This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.
NORML
FEBRUARY 4, 2021
“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".
Project CBD
AUGUST 3, 2020
An oncologist and an osteopath discuss cannabis therapy for cancer patients.
NORML
FEBRUARY 1, 2019
Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. Full text of the study, “Reduction of benzodiazepine use in patients prescribed medical cannabis,” appears in the journal Cannabis and Cannabinoid Research here.
Project CBD
OCTOBER 26, 2023
There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.
NORML
APRIL 30, 2020
.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
Leafly
OCTOBER 12, 2023
Patients require potent pain medication afterwards, often for extended periods. Some years ago, a woman named Jo Cameron had hip surgery but responded in a strange way: she reported a lack of […] The post Cannabinoids, pain, anxiety & fear: The biology of negative emotion appeared first on Leafly.
Project CBD
MARCH 18, 2019
It’s no secret that many cancer patients are using cannabis to help manage pain, fatigue, nausea, and other side effects of chemotherapy.
NORML
NOVEMBER 1, 2021
“When it comes to addressing questions specific to the safety and therapeutic efficacy of cannabis, this publication provides the evidence that patients and their physicians – as well as lawmakers – need to know.”.
Americans for Safe Access
SEPTEMBER 12, 2024
Americans for Safe Access (ASA) fully supports the regulation of cannabinoid products as part of our mission to ensure safe access for patients, and we want you to be successful in your efforts to do so in California. Unfortunately, our efforts to alter the legislation to protect these patients failed, and so did AB 2223.
Veriheal
MAY 16, 2023
Historical sources show that people as early as 300 BCE were aware of cannabis’ appetite-stimulating effects —particularly for sweet and savory food—but who’d have thought that worms (that’s right, worms) also get a case of “the munchies” after being exposed to cannabinoids?
MMJ Recs
MAY 25, 2024
However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.
MMJ Recs
NOVEMBER 20, 2023
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
LifeCannMD
FEBRUARY 1, 2024
Cannabinoids and other compounds found in marijuana have been studied for their potential effects on glaucoma, a group of painful eye conditions that can lead to blindness. The primary reason most glaucoma patients seek medical marijuana treatment is because of lower intraocular pressure (IOP). IOP is extremely painful.
NORML
FEBRUARY 25, 2020
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
MMJ Recs
JUNE 29, 2024
For numerous medical marijuana patients throughout the United States with a medicinal marijuana program, it embodies a vital source of relief and healing. In this comprehensive guide, we’ll go over the importance of proper cannabis storage for patients who use medicinal marijuana as part of their treatment to manage symptoms.
Project CBD
JANUARY 24, 2019
Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Cannabinoid crystals.
Illinois News Joint
OCTOBER 18, 2023
As reported earlier , HB4161 focuses mainly on safety concerns, including permits, licensing, testing, taxes, and a new Hemp Social Equity Fund, but HB4161 also contains amendments that would affect registered Illinois medical cannabis patients and cottage hemp operators as well. Seeds may not be given or sold to any other person.”
United Patients Group
JULY 22, 2023
As medical marijuana gains acceptance in mainstream medicine, patients and healthcare providers need to be well-informed about the various strains available and their unique effects on the body. United Patients Group specializes in providing reliable insights into the therapeutic use of medical marijuana and related plant medicine.
Cannabis Cheri
FEBRUARY 17, 2020
Terpenes interact with cannabinoids and are integral to what scientists call “the entourage effect” of whole plant medicine. This essentially means that the sum of the cannabis plant’s parts is greater than any individual cannabinoid (such as CBD or THC) or terpene. Healing with Marijuana Terpenes.
Project CBD
JULY 2, 2018
Many of our patients have called in asking about cannabinoid hyperemesis syndrome ( CHS ), as this syndrome has been reported in the media numerous times over the past few months. This is a very rare syndrome that occurs in long-term heavy users of THC -rich cannabis. CHS was first reported in the medical literature in 2004.
Project CBD
MAY 3, 2023
Dr. Goldstein has treated thousands of patients with medical cannabis. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids.
LifeCannMD
FEBRUARY 1, 2024
Science has proven that the benefits of cannabis impacts the quality of life of cancer patients in many ways. Research specifically looking at the impact of medical marijuana on the quality of life for cancer patients has shown positive outcomes. We noticed how these symptoms especially affect both physical health and patient morale.
NORML
JUNE 13, 2019
Certain conditions require more cannabinoids than others. Price caps that could favor seriously ill patients/consumers will be an entirely new concept to the cannabis industry, but it’s no innovation. The reality is that cannabinoids have very individualized effects on human beings. Labels on products from the.
FloridaMarijuana.net
MAY 23, 2019
This resin is a sticky and thick-textured substance that contain a variety of terpenes and cannabinoid metabolites. The terpenes dictate how the particular strain of cannabis effects a patient. Schematic of terpene and cannabinoid biosynthesis in cannabis. Terpenes, in part, influence a cannabis strains’ flavor and aroma.
MMJ Recs
JANUARY 10, 2024
Benefits of Medical Marijuana for Pain Relief The medicinal properties of marijuana, particularly its cannabinoids, have been harnessed for centuries. These cannabinoids interact with the endocannabinoid system in the human body, modulating pain perception and inflammation. How Does Medical Cannabis Help Manage Chronic Pain?
Americans for Safe Access
AUGUST 1, 2023
My educational investment in the industry has offered me, through my focus on regulation and policy, the opportunity to collaborate as an advisor with several advocacy and education intermediary organizations focused on federal policy change for medical cannabis patients and a nascent, struggling industry that is supporting them.
CannaMD
OCTOBER 21, 2022
When unpleasant symptoms occur due to consuming large quantities of THC, it is referred to as Acute Cannabinoid Intoxication (ACI), and it can lead to people seeking emergency medical treatment. While cannabis has been shown to offer multiple therapeutic benefits, one drawback is its potential to induce anxiety and paranoia in some users.
Project CBD
AUGUST 6, 2019
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
NORML
JANUARY 27, 2020
Delaware cannabis patients and advocates will gather in Dover on Wednesday to rally support for The Delaware Patient Right to Grow Act, House Bill 243. This change would allow registered patients and registered caregivers to grow medical cannabis at home. Most patients respond best to specific strains of cannabis.
Cannabis Cheri
FEBRUARY 22, 2020
The human body contains two main cannabinoid receptors, CB1 and CB2, both of which are abundant in the skin’s epidermal cells and sensory nerves. Cannabinoid receptors are also found in the skin’s mast cells, which are linked to inflammatory and allergic responses. So what do the cannabinoid receptors do?
Project CBD
SEPTEMBER 12, 2023
Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain.
Cannabis Cheri
FEBRUARY 22, 2020
The human body contains two main cannabinoid receptors, CB1 and CB2, both of which are abundant in the skin’s epidermal cells and sensory nerves. Cannabinoid receptors are also found in the skin’s mast cells, which are linked to inflammatory and allergic responses. So what do the cannabinoid receptors do?
Cannabis Cheri
FEBRUARY 17, 2020
Terpenes interact with cannabinoids and are integral to what scientists call “the entourage effect” of whole plant medicine. This essentially means that the sum of the cannabis plant's parts is greater than any individual cannabinoid (such as CBD or THC) or terpene.
Veriheal
APRIL 12, 2023
In this article, we’ll closely examine this fascinating exploration of cutting-edge research and learn how this study could transform the future of pain relief for spinal cord injury patients. Persistent pain is a prevalent issue among SCI patients, with nearly 80% of affected individuals experiencing some degree of discomfort.
Cannabis Cheri
FEBRUARY 22, 2020
The human body contains two main cannabinoid receptors, CB1 and CB2, both of which are abundant in the skin’s epidermal cells and sensory nerves. Cannabinoid receptors are also found in the skin’s mast cells, which are linked to inflammatory and allergic responses. So what do the cannabinoid receptors do?
Project CBD
APRIL 26, 2023
Cannabinoid receptors CB1 and CB2 are the definitive and best-known targets of endogenous and plant-derived cannabinoids, but they’re far from the only ones. Two recent papers reiterate the point that to really understand cannabinoids (especially CBD) and the ECS, it’s essential to get to know the PPARs. And it worked.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content